CorFlow Therapeutics

• Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

  Phase 2, Not yet recruiting, 250 people, Apr 20, 2025

Sources: clinicaltrials.gov

• Series B

  €44M, Sep 12, 2024

Sources: news.google.com

• Monte Carlo Capital

  Series B, Sep 12, 2024

• KOFA Healthcare

  Series B, Sep 12, 2024

• Unorthodox Ventures

  Series B, Sep 12, 2024

• M&L Investments

  Series B, Sep 12, 2024

• Wellington Partners

  Series B, Sep 12, 2024

• Laerdal Million Lives Fund

  Series B, Sep 12, 2024

• Merieux Equity Partners

  Series B, Sep 12, 2024

• 415 Capital

  Series B, Sep 12, 2024

• Panakès Partners

  Series B, Lead, Sep 12, 2024

• Broadview Ventures

  Series B, Lead, Sep 12, 2024

Sources: startupticker.ch